Welcome to our dedicated page for Fuller H B Co SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The H.B. Fuller Company (NYSE: FUL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. H.B. Fuller is a Minnesota-based issuer that describes itself as the largest pureplay adhesives company in the world, focused on adhesives, sealants, functional coatings and other chemical-based products.
Investors can use this page to access current and historical Forms 8‑K, which H.B. Fuller files to report material events such as quarterly and annual earnings releases, dividend declarations and board changes. Recent 8‑K filings referenced in the input include items under Item 2.02 – Results of Operations and Financial Condition and Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, along with exhibits that attach the related press releases.
In addition to event-driven reports, users can review the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available in the feed). These filings typically provide detailed information on net revenue, margins, net income, cash flow, segment performance, risk factors and other disclosures that complement the non‑GAAP metrics discussed in earnings releases and Regulation G reconciliation tables.
Stock Titan’s platform enhances these documents with AI-powered summaries that explain key sections of lengthy filings, highlight important changes from prior periods and clarify technical language. Real-time updates from EDGAR ensure that new H.B. Fuller filings appear promptly, while links to exhibits make it easier to connect narrative disclosures with supporting press releases and financial tables.
For users researching FUL, this page offers a focused view of H.B. Fuller’s regulatory history, from material event 8‑Ks to periodic reports, helping readers understand how the adhesives manufacturer describes its operations, financial condition, governance and risk profile in formal SEC documents.
H.B. Fuller President and CEO Mastin Celeste Beeks reported multiple equity compensation transactions in H.B. Fuller (FUL) on January 26, 2026. Beeks received an employee stock option grant for 202,009 shares of common stock at an exercise price of
On the same date, 5,851 restricted stock units (RSUs) were converted into an equal number of common shares, and 2,303 shares of common stock were withheld at
After these transactions, Beeks directly owned 28,062 shares of common stock, with an additional 3,500 shares held indirectly through a revocable trust, alongside multiple outstanding option and RSU positions disclosed in the filing.
H.B. Fuller VP, Corporate Controller Robert J. Martsching reported new equity awards and routine tax withholding-related share activity. On January 26, 2026, he received an employee stock option grant for 6,323 shares at an exercise price of $59.81 per share and a grant of 932 restricted stock units that convert into common stock on a 1-for-1 basis. That same day, 176 restricted stock units vested and converted into common shares at $60.07, with 51 shares withheld to cover taxes. After these transactions, Martsching directly owned 15,841.307 shares of common stock, along with multiple outstanding option and unit awards that vest over time.
H.B. Fuller senior vice president Malik Muhammad Shahbaz reported equity compensation changes in H.B. Fuller common stock. On January 26, 2026, he received an employee stock option grant for 16,863 shares at an exercise price of
On the same date, 606 restricted stock units (RSUs) converted into common shares, while 215 shares were withheld to cover taxes on the 606 issued shares. He also received a new award of 2,487 RSUs, which convert into common stock on a 1‑for‑1 basis. Following these transactions, he directly owned 13,289 shares of common stock, along with multiple vested and unvested option and RSU positions.
H.B. Fuller executive Joao Magalhaes reported multiple equity compensation transactions dated January 26, 2026. He received an employee stock option grant for 12,647 shares of common stock at an exercise price of $59.81 per share, which begins vesting in three annual installments starting on that date.
Magalhaes also exercised 149 restricted stock units into common stock, with 71 shares withheld to cover taxes at $60.07 per share, leaving 3,591 common shares held directly. He additionally received 1,865 new restricted stock units that vest in three annual installments beginning January 26, 2027, and continues to hold several fully vested option awards and other option grants with future vesting and expiration dates.
H.B. Fuller Executive Vice President James J. East reported multiple equity transactions dated 01/26/2026. He received an award of 20,938 employee stock options with a $59.81 exercise price that vest in three annual installments beginning 01/26/2027. He also acquired 3,088 restricted stock units (RSUs) that convert into common shares on a 1-for-1 basis and vest over three annual installments beginning 01/26/2027.
On the same date, 692 RSUs were converted to common stock at $60.07, and 157 shares were withheld to cover taxes. After these transactions, East directly held 5,180 shares of common stock and indirectly held 106.19 shares through a 401(k) plan, along with various vested and unvested options, RSUs, and phantom units tied to H.B. Fuller common stock.
H.B. Fuller senior vice president Xinyu Du reported equity compensation and a small share withholding for taxes. On January 26, 2026, Du received an employee stock option grant for 10,961 shares of common stock at an exercise price of
On the same date, 1,616 restricted stock units were granted, which convert into common shares on a 1-for-1 basis and vest in three annual installments beginning January 26, 2027. Du also exercised 199 restricted stock units into common stock at
After these transactions, Du directly held 2,767 shares of common stock, along with multiple vested and unvested stock option and RSU awards with stated expiration and vesting schedules extending through 2036.
H.B. Fuller Executive VP and CFO John J. Corkrean reported multiple equity transactions on January 26, 2026. He received an award of 39,347 employee stock options with an exercise price of
On the same date, 1,404 RSUs were converted into common shares at
H.B. Fuller executive Heather Campe reported multiple equity transactions on common stock and awards dated 01/26/2026.
She received an employee stock option grant for 15,177 shares at an exercise price of
563 restricted stock units were exercised into common shares at
H.B. Fuller director Charles T. Lauber reported the conversion of 1,351 restricted stock units into common stock on 01/24/2026. The restricted stock units converted into common shares on a 1-for-1 basis at a reported price of $60.07 per share, leaving Lauber with 1,351 shares of common stock held directly after the transaction.
Separately, Lauber holds 9,996.65 stock units in the Directors' Deferred Compensation Plan, which will be converted into common stock upon retirement, death, disability or certain specified events, and this amount includes units accrued through a dividend equivalent feature.
H.B. Fuller executive Nathan D. Weaver, Exec VP, Business Transformation, reported multiple equity award transactions dated 01/24/2026. He exercised 1,271 performance stock units and 562 restricted stock units, each converting into common stock at an exercise price of $60.07 per share. The filing also shows an additional 50 common shares acquired from dividend accruals during vesting.
To cover tax obligations on these issuances, 198 shares and 463 shares of common stock were withheld at $60.07 per share. After the transactions, Weaver directly owned 10,774 shares of H.B. Fuller common stock. He also holds various fully vested and time‑vesting employee stock options, restricted stock units, phantom units, and related dividend-equivalent units that are generally convertible into common stock on a 1‑for‑1 basis under the company’s plans.